These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 2158938)
1. Clozapine: benefits and risks. Green AI; Salzman C Hosp Community Psychiatry; 1990 Apr; 41(4):379-80. PubMed ID: 2158938 [No Abstract] [Full Text] [Related]
2. [Experience with Leponex]. Pablo Gotor Díaz D; Marcellino Baras Valenzuela D Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1975; 3(4):281-6. PubMed ID: 1211267 [No Abstract] [Full Text] [Related]
3. [Effect of clozapine on the mental and somatic state of patients]. Nurowska K; Paluba M; Welbel Psychiatr Pol; 1975; 9(4):423-9. PubMed ID: 1161940 [No Abstract] [Full Text] [Related]
4. An atypical responder to clozapine. Wood MJ; Rubinstein M Am J Psychiatry; 1990 Mar; 147(3):369. PubMed ID: 2309959 [No Abstract] [Full Text] [Related]
5. The European experience with use of clozapine. Naber D; Hippius H Hosp Community Psychiatry; 1990 Aug; 41(8):886-90. PubMed ID: 1976107 [TBL] [Abstract][Full Text] [Related]
6. Response to clozapine in chronic psychotic patients. Owen RR; Beake BJ; Marby D; Dessain EC; Cole JO Psychopharmacol Bull; 1989; 25(2):253-6. PubMed ID: 2602519 [No Abstract] [Full Text] [Related]
7. Clozapine: guidelines for clinical management. Lieberman JA; Kane JM; Johns CA J Clin Psychiatry; 1989 Sep; 50(9):329-38. PubMed ID: 2670914 [TBL] [Abstract][Full Text] [Related]
8. Clozapine: a new and unusual antipsychotic agent. Simpson GM; Varga E Psychopharmacol Bull; 1975 Jan; 11(1):14-5. PubMed ID: 235770 [No Abstract] [Full Text] [Related]
13. Treatment outcome with clozapine in tardive dyskinesia, neuroleptic sensitivity, and treatment-resistant psychosis. Small JG; Milstein V; Marhenke JD; Hall DD; Kellams JJ J Clin Psychiatry; 1987 Jul; 48(7):263-7. PubMed ID: 2885310 [TBL] [Abstract][Full Text] [Related]
14. Clozapine versus perphenazine: the value of the biochemical mode of action of neuroleptics in predicting their therapeutic activity. Van Praag HM; Korf J; Dols LC Br J Psychiatry; 1976 Dec; 129():547-55. PubMed ID: 1000139 [TBL] [Abstract][Full Text] [Related]
15. [Clozapine in the treatment of manic states]. Strzyzewski W; Rybakowski J; Chłopocka-Woźniak M; Czerwiński A Psychiatr Pol; 1981; 15(3):331-2. PubMed ID: 7302018 [No Abstract] [Full Text] [Related]
16. [EEG changes with leponex medication]. Kursawe HK; Ludewig L Psychiatr Neurol Med Psychol (Leipz); 1985 Dec; 37(12):705-12. PubMed ID: 4095206 [TBL] [Abstract][Full Text] [Related]
17. Tolerability and therapeutic effect of clozapine. A retrospective investigation of 216 patients treated with clozapine for up to 12 years. Juul Povlsen U; Noring U; Fog R; Gerlach J Acta Psychiatr Scand; 1985 Feb; 71(2):176-85. PubMed ID: 3883696 [TBL] [Abstract][Full Text] [Related]
18. Choosing among old and new antipsychotics. J Clin Psychiatry; 1996 Sep; 57(9):427-38. PubMed ID: 9746456 [No Abstract] [Full Text] [Related]
19. [An experimental study of the spectrum of individual psychotropic activity of clozapine (Leponex)]. Val'dman AV; Kozlovskaia MM Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(11):1710-7. PubMed ID: 1950 [TBL] [Abstract][Full Text] [Related]
20. FDA approves clozapine for treatment of schizophrenia; careful monitoring required. Hosp Community Psychiatry; 1989 Dec; 40(12):1310. PubMed ID: 2591894 [No Abstract] [Full Text] [Related] [Next] [New Search]